Advisory Research’s Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CRHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-179,474
Closed -$4K 430
2022
Q3
$4K Sell
179,474
-37,399
-17% -$18.1K ﹤0.01% 348
2022
Q2
$93K Buy
216,873
+192,444
+788% +$140K 0.01% 320
2022
Q1
$19K Buy
+24,429
New +$17.3K ﹤0.01% 386

Advisory Research's CRHC.WS Position: Q4 2022 in Review

Advisory Research sold out of Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CRHC.WS) in Q4 2022, closing a stake of 179,474 shares — an estimated $4K sold.

Advisory Research first reported a position in CRHC.WS in Q1 2022 and held it in 3 quarters. The position peaked at $93K in Q2 2022. 0 funds tracked by Wall St. Rank hold CRHC.WS as of Q4 2022.

  • Advisory Research reported no remaining Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Advisory Research sold 179,474 Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022, an estimated $4K.
  • Advisory Research first reported a position in Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 3 quarters.
  • Advisory Research's Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $93K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on Advisory Research's 13F filing for Q4 2022, filed 13 Feb 2023.